Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1989 1
1990 1
1991 1
1992 3
1994 1
1995 2
1999 1
2001 3
2002 5
2003 3
2004 2
2005 2
2006 3
2007 2
2008 6
2009 3
2010 3
2011 2
2012 4
2013 3
2014 2
2015 3
2016 3
2017 4
2018 2
2019 7
2020 6
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Does Crizotinib Auto-Inhibit CYP3A in vivo?
Bland AR, Shrestha N, Rosengren RJ, Ashton JC. Bland AR, et al. Among authors: rosengren rj. Pharmacology. 2020;105(11-12):715-718. doi: 10.1159/000506996. Epub 2020 May 27. Pharmacology. 2020. PMID: 32460299
A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor.
Hanif M, Arshad J, Astin JW, Rana Z, Zafar A, Movassaghi S, Leung E, Patel K, Söhnel T, Reynisson J, Sarojini V, Rosengren RJ, Jamieson SMF, Hartinger CG. Hanif M, et al. Among authors: rosengren rj. Angew Chem Int Ed Engl. 2020 Aug 17;59(34):14609-14614. doi: 10.1002/anie.202005758. Epub 2020 Jun 17. Angew Chem Int Ed Engl. 2020. PMID: 32431061
Cannabinoids in the treatment of cancer.
Alexander A, Smith PF, Rosengren RJ. Alexander A, et al. Among authors: rosengren rj. Cancer Lett. 2009 Nov 18;285(1):6-12. doi: 10.1016/j.canlet.2009.04.005. Epub 2009 May 12. Cancer Lett. 2009. PMID: 19442435 Review.
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page